# A Study of Withdrawal of Immunosuppression and Donor Lymphocyte Infusions Following Allogeneic Transplant for Pediatric Hematologic Malignancies

> **NCT01036009** · PHASE2 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 43 (actual)

## Conditions studied

- Acute Leukemia
- Acute Myeloid Leukemia
- Acute Lymphoblastic Leukemia
- Biphenotypic Leukemia
- Pre-leukemic Syndromes
- Monosomy 7
- Bone Marrow Clonal Malformations
- Juvenile Myelomonocytic Leukemia
- Myelodysplastic Syndromes
- Chronic Myelogenous Leukemia

## Interventions

- **OTHER:** Withdrawal of immunosuppression and donor lymphocyte infusion

## Key facts

- **NCT ID:** NCT01036009
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2014-07
- **Final completion:** 2015-07
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2016-06-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01036009

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01036009, "A Study of Withdrawal of Immunosuppression and Donor Lymphocyte Infusions Following Allogeneic Transplant for Pediatric Hematologic Malignancies". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01036009. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*